Dhori virus

From WikiMD's WELLNESSPEDIA

Dhori virus is a type of Thogotovirus that is primarily transmitted by ticks. It was first isolated in India and has since been found in various parts of the world, including Europe and Asia. The virus is named after the location in India where it was first discovered.

Overview[edit]

Dhori virus is a member of the Orthomyxoviridae family, which also includes the Influenza virus. It is one of six known species of Thogotovirus, a genus of viruses that are primarily transmitted by ticks and mosquitoes. Dhori virus is unique among the Thogotoviruses in that it can also be transmitted by aerosol, making it a potential concern for biological warfare or bioterrorism.

Transmission[edit]

The primary vectors for Dhori virus are ticks, particularly those in the Ixodidae family. The virus has been isolated from several species of ticks, including Hyalomma and Rhipicephalus. In addition to tick bites, Dhori virus can also be transmitted by aerosol, a feature that distinguishes it from other Thogotoviruses.

Symptoms and Treatment[edit]

In humans, infection with Dhori virus can cause a range of symptoms, from mild flu-like symptoms to severe neurological disease. The severity of the disease can depend on several factors, including the individual's age and overall health status. There is currently no specific treatment for Dhori virus infection. Management of the disease primarily involves supportive care, such as rest, hydration, and treatment of symptoms.

Research[edit]

Research on Dhori virus is ongoing, with scientists working to better understand the virus's transmission, pathogenesis, and potential treatments. The virus's ability to be transmitted by aerosol has led to it being studied as a potential agent of biological warfare or bioterrorism.

See Also[edit]


Dhori virus[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.